UNSPSC 41151743: Cannabinoid test system

In this classification, a Cannabinoid test system is a device intended to measure Cannabinoid for clinical toxicology purposes. US FDA regulates Cannabinoid test system under 21 CFR 862.3870 and under FDA product code LAT

UNSPSC 41151743 Cannabinoid test system (Commodity) sees minimal relevant recent state and local procurement activity. The code nominally describes equipment for cannabinoid analysis, but the recent opportunities block contains no solicitations for cannabinoid testing systems, laboratory analyzers, or related diagnostic instruments. Instead, the block records 39 recent state and local procurements for unrelated scientific, medical, and research equipment — ranging from X-ray diffractometers and Dynamic Mechanical Analyzers to rapid DNA systems, cold spray additive manufacturing platforms, fire alarm components, and outdoor learning materials. None of these opportunities align with the cannabinoid test system scope.

The single tangential signal is Harris County, Texas's September 2026 RFP for a unit dose packaging system, which could theoretically serve cannabis product manufacturing, but the notice provides no scope detail sufficient to confirm relevance. The geographic spread of recent opportunities clusters in Mississippi (Mississippi State University and University of Mississippi dominate the block), with secondary activity in Texas, Illinois, Wisconsin, Oregon, and Florida. Given the absence of substantive cannabinoid-testing procurement activity in the record and the divergence between the code name and actual recent solicitations, this code does not present actionable pursuit opportunity at present.